Package 68071-3037-8

{"route": ["ORAL"], "spl_id": "1d8e280d-fb14-0e85-e063-6294a90a17a9", "openfda": {"upc": ["0368071303735"], "unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["49db4bcd-8b5a-048d-e054-00144ff88e88"], "manufacturer_name": ["NuCare Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BOTTLE (68071-3037-1)", "package_ndc": "68071-3037-1", "marketing_start_date": "20170303"}, {"sample": false, "description": "12 TABLET in 1 BOTTLE (68071-3037-2)", "package_ndc": "68071-3037-2", "marketing_start_date": "20170303"}, {"sample": false, "description": "8 TABLET in 1 BOTTLE (68071-3037-8)", "package_ndc": "68071-3037-8", "marketing_start_date": "20170303"}], "brand_name": "Valacyclovir hydrochloride", "product_id": "68071-3037_1d8e280d-fb14-0e85-e063-6294a90a17a9", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68071-3037", "generic_name": "Valacyclovir hydrochloride", "labeler_name": "NuCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA077135", "marketing_category": "ANDA", "marketing_start_date": "20100524", "listing_expiration_date": "20261231"}